The authorities of Bosnia and Herzegovina have relied too much on a joint mechanism to procure the Covid-19 vaccine (COVAX), so they have not negotiated directly with pharmaceutical companies. The result of such action is that the state has received the first doses of the vaccine in the second half of February. In the first stage, the administration entity Republic of Srpska has procured the first doses (2000 pieces) of Russian vaccine Sputnik V (which has been used for the vaccination of the medical staff). Also, other administration entity – Federation of Bosnia and Herzegovina has received donation of AstraZeneca vaccine – Covishield India (10000 pieces), but this vaccine has no local licence/approval (it is expected that local Agency for Medicinal products and Medical devices will approve this vaccine after it will be approved/licenced by European Medicines Agency-EMA).
COVID-19 vaccine considerations for Bosnia and Herzegovina
- Can employers mandate the vaccine?
- Who will control delivery of the vaccine?
Federal and provincial governments
- Who covers the cost of the vaccine?
- Where will people get vaccinated?
Government designated vaccination locations
- Is there cultural resistance to getting the vaccine?
Bosnia and Herzegovina, as the state, is composed of three administrative entities, as follows:
*Federation of Bosnia and Herzegovina,
*Republic of Srpska,
and all of these entities have own Public Health Institute, who will be responsible for COVID-19 vaccine delivery.
More InformationGrECo Group, Asinta's partner in Bosnia and Herzegovina.
Employee Benefits in Bosnia and Herzegovina
Get insights on mandatory and common supplementary employee benefits in Bosnia and Herzegovina.
Top 6 Vaccine Considerations
Use our decision matrix to help support your employees.
Page last modified: March 4, 2021
The information presented on this site is current as of the date initially posted; and, because matters related to COVID-19, the vaccine, and compliance measures are changing so quickly, it may not be current as of the date you read it. While the information gathered here is from Asinta global partners who are subject matter experts in their respective fields, this information is not meant to be a substitute for individual legal or medical advice, or as a substitute for advice in your specific situation.